Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuko Fujita

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Hematological Oncology|April 10, 2009
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphomaRie Hyo, Naoto Tomita, Kengo Takeuchi, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of ageHirotaka Takasaki, Chizuko Hashimoto, Atsuko Fujita, et al.
Leukemia Research|August 10, 2013
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneReina Watanabe, Naoto Tomita, Kumiko Kishimoto, et al.
British Journal of Haematology|February 26, 2013
R-CHOP therapy alone in limited stage diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Kazuho Miyashita, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Hematological Oncology|April 10, 2009
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphomaRie Hyo, Naoto Tomita, Kengo Takeuchi, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of ageHirotaka Takasaki, Chizuko Hashimoto, Atsuko Fujita, et al.
Leukemia Research|August 10, 2013
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneReina Watanabe, Naoto Tomita, Kumiko Kishimoto, et al.
British Journal of Haematology|February 26, 2013
R-CHOP therapy alone in limited stage diffuse large B-cell lymphomaNaoto Tomita, Hirotaka Takasaki, Kazuho Miyashita, et al.
Pageof 2